3 April 2025

Influenza H5N1 in mammals – immunity vaccination

spotlight topic:

Influenza H5N1 in mammals

4. Immunity/Vaccination Published 3 April 2025 | Updated 9 May 2025

Li, Q. et al. (2025) Highly pathogenic avian influenza H5N1 clade 2.3.4.4b hemagglutinin and/or neuraminidase elicit immunity in a recombinant nanoparticle vaccine. Cell Biomaterials, no. 100070. https://doi.org/10.1016/j.celbio.2025.100070
Levine, M.Z. et al. (2025) Neutralizing antibody response to influenza A(H5N1) virus in dairy farm workers, Michigan, USA. Emerging Infectious Diseases, 31 (4), pp. 876–878. https://doi.org/10.3201/eid3104.250007
Sun, X. et al. (2025) Effect of prior Influenza A(H1N1)pdm09 virus infection on pathogenesis and transmission of human Influenza A(H5N1) Clade 2.3.4.4b virus in ferret model. Emerging Infectious Diseases, 31 (3), pp. 458-466. https://doi.org/10.3201/eid3103.241489
Domínguez-Odio, A. et al. (2025) Research publications and global manufacture of veterinary vaccines against avian influenza A (2019-2023). Frontiers in Veterinary Science, 12. https://doi.org/10.3389/fvets.2025.1394675

Claiming CPD for reading inFOCUS articles Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process. Online full-text available to Library members A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.